Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2024 Mar 21;14:1335005. doi: 10.3389/fphar.2023.1335005

Corrigendum: Combination effect of three main constituents from Sarcandra glabra inhibits oxidative stress in the mice following acute lung injury: a role of MAPK-NF-κB pathway

Chunping Liu 1,2,, Jian-Xing Liu 1,, Jiangyong Gu 3, Fang Liu 4, Jin Hua Li 1, Bin Yang 5, Yuan Zheng 1, Jie Li 1, Shou-Hai Wu 1, Qing-He Wu 1, Xian Zhang 1, Long-Mei Li 1, Hai-Long Yang 1, Lei Wang 1,*, Xiong Li 1,*
PMCID: PMC10993012  PMID: 38576894

In the published article, there was an error in Figures 7B, C as published. The p38 strips in Figures 7B, C is a duplicate, which was incorrectly pasted during data processing.

FIGURE 7.

FIGURE 7

Effects of C, R, I (1, 2, 3) on p38 MAPK, ERK, and JNK activation in RAW264.7 cells stimulated by LPS. Pretreatment with; (A) C; (B) R; (C) I; Values are indicated as the mean of four mice per group. *p < 0.05, **p < 0.01 as compared to the LPS group, #p < 0.05, ##p < 0.01 as compared to the normal control group. Combined effect of C + R + I on inhibiting the activation of MAPK-NF-κB signaling pathway.

The corrected Figures 7B, C and its caption Effects of C, R, I (1, 2, 3) on p38 MAPK, ERK, and JNK activation in RAW264.7 cells stimulated by LPS appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES